The reported failure "pint and part dropped - suspected clotting" occurred during use.The patient was infected with covid-19.Covid-19 diseases can be associated with intravascular coagulation activation, microcirculation disorders and increased risk of thromboembolism despite good systemic anticoagulation.Due to the high risk of spreading the sars-cov-2 virus outside the healthcare environment, a technical investigation of this hls set is not possible as the laboratory of maquet cardiopulmonary (b)(4) is not suitable for who risk group 3.Furthermore, no external laboratory could be found that could carry out the investigation on our behalf.As stated in the event description of the complaint (b)(4) it is suspect that one or more of the 4 outflow ports post centrifugal pump have become occluded secondary to clot.And also the patient was coagulopathic.As no further investigation in the laboratory of the manufacturer is possible a review of already investigated complaint was performed.A similar case was already investigate under complaint# (b)(4): as stated in the investigation report of ot# (b)(4) clots could be found inside the oxygenator.The most probable root cause for the pressure drop are clots in the oxygenator leading to a blockage and thus an extension of the diffusion path lowering the oxygenating performance.According to the risk assessment (hls set advanced 5.0 / hls set advanced 7.0, dms # (b)(4)) following causes could lead to coagulation: de-airing luer lock connection too loose, air remains in or enters the circuit, hemostasis, air or blood remains in luer lock access port, too low anticoagulation, too low at level, effect of heparin is too limited, protamine sulfate enters the hls set, administration of substitution of congealable substance such as plateles, (consumption) coagulopathy, thrombozytopenia.Device history record (dhr) review was performed and there were no references found, which are indicating a nonconformance of the product in question.The reported failure "pint and part dropped - suspected clotting" occurred during use and could be confirmed.The device is directly involved in the event.The occurrence rate was calculated for the reported issue and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonarys trending program and additional investigations or corrections will be implemented in case of adverse trending.
|
It was reported from a customer from the us that customer increase the rpms to 4500 to maintain 5 lpm.Pint and part pressure on the hls module have dropped along with flow to the patient, but delta p is the same.It is suspect that one or more of the 4 outflow ports post centrifugal pump have become occluded secondary to clot.The patient is covid-19 positive, and the patient is coagulopathic.Customer will continue to support the patient on the current hls set till it fails.No information provided that there was an exchange.No indication of actual or potential for harm or death reported.Complaint id: (b)(4).
|